Literature DB >> 2212349

Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events.

B Schneider1, P Hanrath, P Vogel, T Meinertz.   

Abstract

Transthoracic and transesophageal echocardiography was performed in 23 consecutive adult patients with an atrial septal aneurysm. In three patients with a cerebrovascular event the diagnosis was established by the transesophageal approach only. Interatrial shunting on transthoracic imaging with use of echocardiographic contrast imaging or Doppler color mapping, or both, was detected in 7 (41%) of 17 patients. On performing contrast imaging in combination with color flow mapping during transesophageal echocardiography, positive shunting was demonstrated in 15 (83%) of 18 patients. Echocardiographic identification of multiple fenestrations (n = 4) and thrombus within the aneurysm (n = 2) could be achieved for the first time by transesophageal ultrasound application. Cerebrovascular events occurred in 12 (52%) of 23 patients and were regarded as being definitely thromboembolic in 10 (43%); 8 (67%) of the 12 patients had repeated cerebral events. Except for mitral valve prolapse in one patient, no other potential cardiac source of embolism could be identified despite the use of transesophageal echocardiography. A thickening of the aneurysmal membrane greater than or equal to 5 mm was found in 9 (75%) of 12 patients with versus 3 (27%) of 11 patients without a cerebrovascular event (p less than 0.05); this proved to be the only significant difference between the two patient groups. The mechanism of embolization may be both primary thrombus formation within the aneurysm and paradoxic embolization through an interatrial communication as demonstrated by the findings in two patients. It is concluded that atrial septal aneurysm is a cardiac abnormality with thromboembolic potential. In patients with this lesion and a history of an embolic event, long-term anticoagulant therapy is indicated.

Entities:  

Mesh:

Year:  1990        PMID: 2212349     DOI: 10.1016/s0735-1097(10)80354-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  26 in total

Review 1.  Transoesophageal echocardiography.

Authors:  J E Sanderson; W W Chan
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

Review 2.  Echocardiography and the general physician.

Authors:  G J Heatlie; M Giles
Journal:  Postgrad Med J       Date:  2004-02       Impact factor: 2.401

Review 3.  [Patent foramen ovale, atrial septum aneurysm, and stroke. An examination of the status of recent evidence].

Authors:  K Kraywinkel; M Jauss; H-C Diener; C Weimar
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

Review 4.  Transesophageal echocardiography and stroke.

Authors:  Timothy D Woods
Journal:  Curr Atheroscler Rep       Date:  2005-07       Impact factor: 5.113

5.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

6.  Recurrent stroke on imaging and presumed paradoxical embolism: a cross-sectional analysis.

Authors:  Georgios D Kitsios; Aaron Lasker; Jasmeet Singh; David E Thaler
Journal:  Neurology       Date:  2012-03-14       Impact factor: 9.910

Review 7.  Stroke in younger patients: the heart of the matter.

Authors:  P E Cotter; M Belham; P J Martin
Journal:  J Neurol       Date:  2010-07-11       Impact factor: 4.849

Review 8.  Current status of percutaneous PFO closure.

Authors:  N Rohrhoff; J P Vavalle; S Halim; T L Kiefer; J K Harrison
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

9.  Evaluation of the relationship between atrial septal aneurysm and cardiac arrhythmias via P-wave dispersion and signal-averaged P-wave duration.

Authors:  Onur Sinan Deveci; Kudret Aytemir; Sercan Okutucu; Erol Tulumen; Hakan Aksoy; Ergun Baris Kaya; Banu Evranos; Giray Kabakci; Lale Tokgozoglu; Ali Oto; Hilmi Ozkutlu
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

10.  Interactions between cardiovascular and cerebrovascular disease.

Authors:  Giuseppe Di Pasquale; Stefano Urbinati; Enrica Perugini; Simona Gambetti
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.